title: Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
authors.affiliation: Division of Hematology/Oncology, Comprehensive Cancer Center, and Center for Biostatistics, The Ohio State University, Columbus, Ohio 43210, USA.
authors.forename: Charles F
authors.initials: CF
authors.lastname: Eisenbeis
authors.forename: Andrew
authors.initials: A
authors.lastname: Grainger
authors.forename: Beth
authors.initials: B
authors.lastname: Fischer
authors.forename: Robert A
authors.initials: RA
authors.lastname: Baiocchi
authors.forename: Lester
authors.initials: L
authors.lastname: Carrodeguas
authors.forename: Sameek
authors.initials: S
authors.lastname: Roychowdhury
authors.forename: Lei
authors.initials: L
authors.lastname: Chen
authors.forename: Amy L
authors.initials: AL
authors.lastname: Banks
authors.forename: Thomas
authors.initials: T
authors.lastname: Davis
authors.forename: Donn
authors.initials: D
authors.lastname: Young
authors.forename: Nicole
authors.initials: N
authors.lastname: Kelbick
authors.forename: Julie
authors.initials: J
authors.lastname: Stephens
authors.forename: John C
authors.initials: JC
authors.lastname: Byrd
authors.forename: Michael R
authors.initials: MR
authors.lastname: Grever
authors.forename: Michael A
authors.initials: MA
authors.lastname: Caligiuri
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Porcu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy*; D008297:Male; D051379:Mice; D016513:Mice, SCID; D008875:Middle Aged; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007376:Interleukin-2; D000069283:Rituximab